Methadon Hcl Tiofarma (Methadone Hydrochloride)

Methadone hydrochloride works by binding to and activating µ‑opioid receptors in the central nervous system. This activation provides analgesia and, in the context of opioid dependence, reduces withdrawal symptoms and blocks the euphoric effects of other opioids.

The appropriate dose of Methadon Hcl Tiofarma is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, response to therapy, and any relevant comorbidities.

Safety data for methadone in pregnancy and lactation are limited. It may be used when the benefits outweigh potential risks, but prescribers should consider fetal exposure, possible neonatal withdrawal, and advise on breastfeeding based on current clinical guidelines.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both methadone and buprenorphine are used for opioid dependence, but methadone is a full µ‑opioid agonist offering stronger analgesia, while buprenorphine is a partial agonist with a ceiling effect on respiratory depression, which may result in a different safety profile and dosing schedule.

Methadon Hcl Tiofarma should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

The product is formulated for oral administration. It is taken by mouth with or without food as directed by the prescribing clinician, who will provide specific instructions on timing and any necessary monitoring.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, and cardiac arrhythmias such as QT‑interval prolongation. Patients should be monitored closely for signs of overdose, severe sedation, or cardiac symptoms.

Methadon Hcl Tiofarma is contraindicated in individuals with known hypersensitivity to methadone, those with severe respiratory insufficiency, uncontrolled cardiac arrhythmias, or in patients taking certain interacting medications that could lead to dangerous accumulation.